Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
GI bleeding more common with rivaroxaban than other direct oral anticoagulants
Evaluation of bleeding in patients receiving direct oral anticoagulant | VHRM
Figure 43, Forest plot for gastrointestinal bleeding—apixaban, rivaroxaban, or edoxaban (treatment) versus dabigatran (control) (observational) - Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update - NCBI Bookshelf
ESC 2015 Meeting Report
Anticoagulation in the Post-Warfarin Era: Where Are We Today?
Frontiers | Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies | Pharmacology
Eliquis vs Xarelto: Which Is Better in Afib? | MedPage Today
Better clinical outcomes with DOACs vs. warfarin in patients with NVAF and low body weight - PACE-CME
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
GI bleeding on anticoagulants
Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
Management of anticoagulation in patients with acute gastrointestinal bleeding - ScienceDirect
Comparison of NOACs in risk of major bleeding in patients with AF. AF =... | Download Scientific Diagram
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
Overall Rates of GI Bleeding by Treatment Arm | Download Table
What gastroenterologists should know about direct oral anticoagulants - Digestive and Liver Disease
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
New predictive model for acute gastrointestinal bleeding in patients taking oral anticoagulants: A cohort study - Shimomura - 2018 - Journal of Gastroenterology and Hepatology - Wiley Online Library
Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation | Heart
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study - Gastroenterology
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study - Clinical Gastroenterology and Hepatology
